Serum Raman spectroscopy can be used to screen patients with early rheumatoid arthritis.

In this study, Raman spectroscopy was used to analyze the serum of patients with early rheumatoid arthritis (RA), and to explore the screening value of Raman spectroscopy in patients with early RA. 216 patients were included in the study. Fasting venous blood was collected for routine biochemical detection, and the remaining samples were tested by serum Raman spectroscopy. Support vector machine (SVM) was used for model building and training. The area under the curve (AUC) values of the model were as follows: (1) healthy group vs early RA group: 0.860, (2) healthy group vs non-early RA group: 0.903, (3) early RA group vs non-early RA group: 0.918. This study shows that serum Raman spectroscopy has a good ability to screen RA and can be staged according to the course of the disease, which can provide new ideas and technical support for the diagnosis or screening of early RA. This article is protected by copyright. All rights reserved.